MMP9 and neuropathy: In CIPN, the chemotherapy-induced upregulation of MMP9 might similarly initiate or exacerbate demyelination, establishing a direct link between MMP9 activity and the sensory disturbances characteristic of chemotherapy-induced neuropathy (Tonello et al., 2019).